Analysis Article • May 01

Over the last 7 days, the Clinical Research and Equipment industry has risen 5.4%, driven by gains from AddLife of 9.6%. In the past year, the industry is down 10%. Looking forward, earnings are forecast to grow by 19% annually.
Has the Swedish Clinical Research and Equipment Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Fri, 26 Jun 2026 | SEK 30.6b | SEK 14.6b | -SEK 871,304,353.00 | 35.8x | -35.2x | 2.1x |
| Sun, 24 May 2026 | SEK 30.0b | SEK 14.6b | -SEK 849,175,077.00 | 37.7x | -35.4x | 2.1x |
| Tue, 21 Apr 2026 | SEK 31.0b | SEK 14.6b | -SEK 971,664,077.00 | 35.9x | -31.9x | 2.1x |
| Thu, 19 Mar 2026 | SEK 27.1b | SEK 14.6b | -SEK 838,374,077.00 | 32.7x | -32.3x | 1.9x |
| Sat, 14 Feb 2026 | SEK 27.0b | SEK 14.9b | -SEK 553,301,427.00 | 32.8x | -48.8x | 1.8x |
| Mon, 12 Jan 2026 | SEK 30.7b | SEK 14.9b | -SEK 744,515,427.00 | 48x | -41.3x | 2.1x |
| Wed, 10 Dec 2025 | SEK 32.8b | SEK 14.9b | -SEK 744,515,427.00 | 54.3x | -44.1x | 2.2x |
| Fri, 07 Nov 2025 | SEK 34.6b | SEK 14.7b | -SEK 742,825,012.00 | 54x | -46.5x | 2.3x |
| Sun, 05 Oct 2025 | SEK 34.5b | SEK 14.7b | SEK 61.3m | 58.7x | 562.8x | 2.4x |
| Tue, 02 Sep 2025 | SEK 35.3b | SEK 14.7b | SEK 60.9m | 57.8x | 580.6x | 2.4x |
| Thu, 31 Jul 2025 | SEK 36.5b | SEK 14.8b | SEK 186.0m | 59.1x | 196.4x | 2.5x |
| Sat, 28 Jun 2025 | SEK 46.7b | SEK 16.6b | SEK 405.8m | 68.5x | 115.1x | 2.8x |
| Mon, 26 May 2025 | SEK 45.0b | SEK 16.6b | SEK 401.3m | 68.5x | 112.2x | 2.7x |
| Wed, 23 Apr 2025 | SEK 41.0b | SEK 16.6b | SEK 580.4m | 44.3x | 70.6x | 2.5x |
| Fri, 21 Mar 2025 | SEK 37.3b | SEK 16.6b | SEK 614.9m | 38x | 60.6x | 2.2x |
| Sun, 16 Feb 2025 | SEK 43.7b | SEK 17.0b | -SEK 1,038,511,426.00 | 42.5x | -42.1x | 2.6x |
| Tue, 14 Jan 2025 | SEK 41.1b | SEK 16.7b | -SEK 1,152,911,426.00 | 43.2x | -35.6x | 2.5x |
| Thu, 12 Dec 2024 | SEK 44.5b | SEK 16.7b | -SEK 1,152,911,426.00 | 51.4x | -38.6x | 2.7x |
| Sat, 09 Nov 2024 | SEK 44.3b | SEK 16.8b | -SEK 958,019,827.00 | 50.7x | -46.3x | 2.6x |
| Mon, 07 Oct 2024 | SEK 47.2b | SEK 16.7b | -SEK 988,175,491.00 | 58.9x | -47.7x | 2.8x |
| Wed, 04 Sep 2024 | SEK 48.6b | SEK 16.7b | -SEK 987,374,492.00 | 61.8x | -49.2x | 2.9x |
| Fri, 02 Aug 2024 | SEK 49.2b | SEK 16.7b | -SEK 1,128,120,510.00 | 61.9x | -43.6x | 2.9x |
| Sun, 30 Jun 2024 | SEK 42.0b | SEK 16.3b | -SEK 1,188,686,510.00 | 55.3x | -35.3x | 2.6x |
| Tue, 28 May 2024 | SEK 43.1b | SEK 16.3b | -SEK 1,188,686,510.00 | 61.1x | -36.2x | 2.6x |
| Thu, 25 Apr 2024 | SEK 37.9b | SEK 16.1b | -SEK 1,234,732,213.00 | 36.3x | -30.7x | 2.4x |
| Sat, 23 Mar 2024 | SEK 38.9b | SEK 16.0b | -SEK 1,122,792,210.00 | 36x | -34.6x | 2.4x |
| Mon, 19 Feb 2024 | SEK 41.0b | SEK 16.0b | -SEK 1,409,735,350.00 | 50.7x | -29.1x | 2.6x |
| Wed, 17 Jan 2024 | SEK 36.9b | SEK 15.5b | -SEK 1,393,723,683.00 | 45.2x | -26.5x | 2.4x |
| Fri, 15 Dec 2023 | SEK 37.4b | SEK 15.5b | -SEK 1,393,723,683.00 | 46.1x | -26.8x | 2.4x |
| Sun, 12 Nov 2023 | SEK 31.2b | SEK 15.4b | -SEK 1,256,647,710.00 | 34x | -24.8x | 2x |
| Tue, 10 Oct 2023 | SEK 25.6b | SEK 15.1b | -SEK 1,134,516,711.00 | 36.6x | -22.6x | 1.7x |
| Thu, 07 Sep 2023 | SEK 29.6b | SEK 15.1b | -SEK 1,133,372,831.00 | 36.6x | -26.1x | 2x |
| Sat, 05 Aug 2023 | SEK 32.1b | SEK 15.1b | -SEK 213,871,038.00 | 46.7x | -150.2x | 2.1x |
| Mon, 03 Jul 2023 | SEK 36.5b | SEK 14.6b | -SEK 172,476,038.00 | 36.1x | -211.7x | 2.5x |
-211.7x
How does Swedish Clinical Research and Equipment compare with similar industries?
| SE Market | -0.80% | |
| Healthcare | 2.52% | |
| Life Sciences | 5.43% | |
| Clinical Research and Equipment | 5.43% | |
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| ALIF B AddLife | SEK 170.50 | 9.6% +SEK 1.8b | -7.0% | PE36.6x | |
| MCAP MedCap | SEK 518.00 | 8.5% +SEK 606.8m | 16.1% | PE34.5x | |
| GENO Genovis AB (publ.) | SEK 19.36 | 5.7% +SEK 68.7m | -26.9% | PE52.6x | |
| PRO Promimic | SEK 10.30 | 1.0% +SEK 1.9m | -39.6% | PS3.9x | |
| MAGLE Magle Chemoswed Holding | SEK 1.02 | 2.0% +SEK 563.9k | -96.2% | PS0.1x |